Daniil Gataulin
Stock Analyst at Chardan Capital
(0)
# 4630
Out of 5,253 analysts
65
Total ratings
29.79%
Success rate
-16.03%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Ocugen | Maintains: Buy | 6 6 | 0.71 | 745.07% | 8 | Jan 23, 2025 | |
Unity Biotechnology | Initiates Coverage On: Buy | 6 | 2.28 | 163.16% | 1 | Jan 10, 2025 | |
Oculis Holding | Maintains: Buy | 28 28 | 22.04 | 27.04% | 4 | Jan 7, 2025 | |
Cognition Therapeuti... | Maintains: Buy | 11 11 | 0.73 | 1406.85% | 4 | Dec 19, 2024 | |
CervoMed | Downgrades: Neutral | n/a | n/a | n/a | 3 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 64 64 | 15.06 | 324.97% | 3 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 7 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 52 52 | 7.47 | 596.12% | 8 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 36 36 | 6.26 | 475.08% | 2 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 6 6 | 0.93 | 545.16% | 3 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 28 33 | 7.85 | 320.38% | 8 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 4 40 | 4.42 | 804.98% | 5 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 220 220 | 3.37 | 6428.19% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 22 13 | n/a | n/a | 2 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 5 3 | n/a | n/a | 2 | Sep 28, 2022 |